Mode
Text Size
Log in / Sign up

Depression linked to higher risk of progression from mild cognitive impairment to Alzheimer's disease and dementia in adults

Depression linked to higher risk of progression from mild cognitive impairment to Alzheimer's…
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider screening for depression in MCI patients given its potential association with progression to dementia.

This systematic review and meta-analysis examined the relationship between depression and the risk of progression from mild cognitive impairment to Alzheimer's disease or all-cause dementia in adults. The analysis included seventeen studies and assessed both unadjusted and adjusted risks for conversion to these conditions over a follow-up period ranging from six months to twelve years.

The authors observed that depression was associated with an increased risk of progression overall and specifically to Alzheimer's disease in unadjusted analyses. After statistical adjustment, the association with progression to Alzheimer's disease remained non-significant, while the risk for all-cause dementia showed a modest increase. The study noted that the magnitude and consistency of this association warrant careful interpretation.

Key limitations highlighted by the authors include very high heterogeneity across the included studies and a resulting very low certainty of evidence. The authors caution against overstating the strength of the link between depression and dementia progression. They emphasize the importance of screening for and managing depression in patients with mild cognitive impairment, suggesting that integrating mental health care into cognitive disorder clinics may improve outcomes and potentially delay onset.

The clinical relevance lies in the potential for better patient management rather than definitive causal proof. Clinicians should consider these results as supportive for holistic care approaches but must acknowledge the substantial variability in the underlying data.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BackgroundMild cognitive impairment (MCI) is a transitional stage between normal aging and dementia, with annual conversion rates to Alzheimer's disease (AD) or all-cause dementia estimated at 10%−15%. The role of depression as a prognostic factor for dementia progression remains unclear. This systematic review and meta-analysis aimed to clarify the association between depression and risk of conversion from MCI to AD and all-cause dementia.MethodsWe conducted a systematic review and meta-analysis of longitudinal cohort studies following PRISMA 2020 guidelines. PubMed, PsycINFO, Web of Science, and Scopus were searched. Eligible studies included adults with MCI, depression assessed by clinical diagnosis or validated scales, and reported hazard ratios (HRs) for progression to dementia. Random-effects meta-analyses were performed for unadjusted and adjusted HRs. Risk of bias was assessed using the Newcastle–Ottawa Scale, and certainty of evidence was evaluated with GRADE.ResultsSeventeen studies were included, with follow-up ranging from 6 months to 12 years. In unadjusted analyses, baseline depression was associated with increased risk of progression overall (HR 1.66, 95% CI 1.22–2.26); however, heterogeneity across studies was high (I2 = 99.1%), limiting confidence in the pooled estimate. The association was significant for progression to AD (HR 1.57, 95% CI 1.15–2.15; I2 = 99.4%), but not for all-cause dementia (HR 1.95, 95% CI 0.85–4.48; I2 = 90%). In adjusted analyses, depression remained associated with increased progression risk overall (HR 1.21, 95% CI 1.05–1.39), with high heterogeneity (I2 = 99.8%). The association was statistically significant for all-cause dementia (HR 1.24, 95% CI 1.01–1.52; I2 = 78.8%), but not for AD (HR 1.18, 95% CI 0.95–1.47; I2 = 99.8%). Sensitivity analyses confirmed robustness of findings, and publication bias was not detected. Certainty of evidence was rated very low due to heterogeneity.ConclusionDepression appears to be associated with an increased risk of progression from MCI to dementia; however, the very high heterogeneity and very low certainty of evidence substantially limit confidence in the magnitude and consistency of this association. These findings highlight the importance of depression screening and management in MCI populations. Integrating mental health care into cognitive disorder clinics may improve patient outcomes and potentially delay dementia onset.Systematic Review registration identifier: CRD420261308245.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.